Counterfeit cancer drugs: Most drug samples tested are genuine, says Delhi govt

Most of the cancer drug samples taken from private pharmacies by the Delhi government to check their purity are genuine, health department officials said on Thursday. The government collected 160 samples from private pharmacies in June, of which 127 were specifically cancer drugs, as part of an investigation into counterfeit drug rackets.
 
Samples were taken from distribution hubs near cancer centres in South Delhi, including AIIMS, Safdarjung Hospital, and Lok Nayak Hospital adjoining the Central Delhi zone, Daryaganj and Bhagirath Place near Rajiv Gandhi Hospital in Rohini, and Laxmi Nagar in East Delhi. The samples included Imatinib (Veenat 400), a combination drug (used alone or with other medicines) to treat different cancers, and Capegard 500, used for breast, colon, and rectum cancers.
 
“Of the 127 samples of cancer drugs collected from various outlets in Delhi, 75 samples have been declared to be genuine and complying with the prescribed quality norms. The report for the remaining 52 samples is awaited. All the samples whose reports have been received so far are declared to be of standard quality. For the other 30 samples of the total remaining 52 samples, the inquiry report will also likely come soon,” said a senior official from the drug control department on Thursday, requesting anonymity.
 
In June, health minister Pankaj Singh ordered an investigation following multiple complaints about counterfeit drugs being sold in the city.
 
Explaining how the drugs were tested, the official cited above said that after the samples were collected, they were sent to labs for testing along with the chemicals and other substances required for the tests.

Related Posts

IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

Bhubaneswar: Researchers from the Sensors and Spectroscopy Research Group, School of Electrical and Computer Sciences (SECS), Indian Institute of Technology (IIT) Bhubaneswar, led by Dr. Sayan Dey, have made significant…

Almost 85% of overcharged amount claimed by NPPA yet to be recovered

New Delhi: India’s drug price monitoring and enforcing authority, the National Pharmaceutical Pricing Authority (NPPA), has almost 85 per cent of the amount it demanded from the pharma industry on…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Minister JP Nadda launches drug registry to standardise medicine-related information

Minister JP Nadda launches drug registry to standardise medicine-related information

Pharmexcil urges companies to adopt NCB voluntary code to prevent chemical diversion into illegal drug production

Pharmexcil urges companies to adopt NCB voluntary code to prevent chemical diversion into illegal drug production

Govt review finds no common thread in post-delivery deaths

Gurgaon call centre busted for cheating people with fake weight-loss products, 3 women held

Gurgaon call centre busted for cheating people with fake weight-loss products, 3 women held

Madhya Pradesh toddler loses vision after doctor administers drops, probe underway

Madhya Pradesh toddler loses vision after doctor administers drops, probe underway

CDSCO Mandates SUGAM Portal for Post-Approval Changes (PAC) to Vaccine and Anti-Sera Import Licences

CDSCO Mandates SUGAM Portal for Post-Approval Changes (PAC) to Vaccine and Anti-Sera Import Licences